Eunice Kagucia

Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalence.Gallagher KE Odiwour F Bottomley C Ojal J Adamu A Muthumbi E Kagucia EW Hammitt LL Massora S Sigauque B Chauque A Vilanculos L Verani JR da Gloria Carvalho M von Gottberg A Kleynhans J Madhi SA Olwagen CP Mackenzie G Salaudeen R Gierke R Kobayashi M Pelton S Yildirim I Thomas S Tunali A Farley M Swarthout TD Kalizang'oma A Heyderman RS French N Choi Y Andrews N Ladhani S Miller E Scott JAG
Lancet Microbe, (2026). 7:101301

Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalence.Gallagher KE Odiwour F Bottomley C Ojal J Adamu A Muthumbi E Kagucia EW Hammitt LL Massora S Siga├║que B Cha├║que A Vilanculos L Verani JR da Gloria Carvalho M von Gottberg A Kleynhans J Madhi SA Olwagen CP Mackenzie G Salaudeen R Gierke R Kobayashi M Pelton S Yildirim I Thomas S Tunali A Farley M Swarthout TD Kalizang'oma A Heyderman RS French N Choi Y Andrews N Ladhani S Miller E Scott JAG
Lancet Microbe, (2026). 7:101301

Seroprevalence of antibodies against diphtheria, tetanus, and pertussis over a 12-year period in children in Kilifi, Kenya (2009-2021).Mburu CN Ojal J Selim R Ombati R Akech D Karia B Tuju J Sigilai A Smits G van Gageldonk PGM van der Klis FRM Flasche S Kagucia EW Scott J Adetifa I
Int J Infect Dis, (2026). 164:108396

Active vaccine safety surveillance: Experience from a prospective cohort event monitoring study of COVID-19 vaccines in Kenya.Odhiambo DB Akech D Karia B Kimani M Sang S Sigilai A Voller S Mataza C Mang'ong'o D Jalang'o R Mandale M Etyang AO Scott JAG Agweyu A Kagucia EW
PLOS Glob Public Health, (2025). 5:e0005080

A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia.Lucinde RK Gathuri H Mwaniki P Orindi B Otieno EO Mwakio S Mulemi L Isaaka L Shangala J Saisi M Isinde E Oginga IN Wachira AW Manuthu E Kariuki H Asaava P Nyikuli J Wekesa C Otedo A Bosire H Okoth SB Ongalo W Mukabi DM Lusamba W Muthui B Adembesa I Mithi C Sood M Aliyan NA Gituma B Matiko MG Omondi CA Ombajo LA Kirui N Ochola L Abdi AI Kagucia EW English M Hamaluba M Ochola-Oyier I Kamuya D Bejon P Barasa E Agweyu A Akech S Etyang AO
N Engl J Med, (2025). 393:2187-2197

The impact of 10-valent pneumococcal conjugate vaccine on the incidence of admissions to hospital with hypoxaemic and non-hypoxaemic pneumonia in Kenyan children.Haeusler IL Kagucia EW Bottomley C Otiende M Nyiro J Scott JAG
PLOS Glob Public Health, (2025). 5:e0004888

Lessons learnt during establishment of COVID-19 active vaccine safety surveillance in nine African countries.Cutland CL Gutu K Yun JA Izu A Mahtab S Peter J Ansah NA Obaro S Tilahun B Jambo K Sow S Kagucia EW Chicumbe S Dlamini T Browne M Clothier H Griffin J Jiang Y Lee A Ghebreab L Madhi SA Black SB Active vaccine safety surveillance team
Vaccine, (2025). 62:127441

Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009-2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016.Mburu CN Ojal J Selim R Ombati R Akech D Karia B Tuju J Sigilai A Smits G van Gageldonk PGM van der Klis FRM Flasche S Kagucia EW Scott JAG Adetifa IMO
Vaccine, (2025). 61:127425

Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration.Kagucia EW Voller S Ziraba AK Bigogo G Munywoki PK Makobu K Nokes DJ Nyagwange J Orlendo C Akech D Sigilai A Onyango C Juma B Herman-Roloff A Munyua P Apondi C Lidechi S Audi A Ouma A Aol G Misore T Nasimiyu C Onyango D Lo T Kasera K Jalang'o R Kingwara L Adetifa I Etyang AO Warimwe G Agweyu A Scott JAG
Gates Open Res, (2025). 8:60

Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project.Yang Y Knoll MD Herbert C Bennett JC Feikin DR Garcia Quesada M Hetrich MK Zeger SL Kagucia EW Xiao M Cohen AL van der Linden M du Plessis M Yildirim I Winje BA Varon E Valenzuela MT Valentiner-Branth P Steens A Scott JA Savrasova L Sanz JC Khan AS Oishi K Nzoyikorera N Nuorti JP Mereckiene J McMahon K McGeer A Mackenzie GA MacDonald L Ladhani SN Kristinsson KG Kleynhans J Kellner JD Jayasinghe S Ho PL Hilty M Hammitt LL Guevara M Gilkison C Gierke R Desmet S De Wals P Dagan R Colzani E Ciruela P Chuluunbat U Chan G Camilli R Bruce MG Brandileone MC Ampofo K O'Brien KL Hayford K Pserenade Team
J Infect, (2025). 90:106426

Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trial.Coldiron ME Soumana I Baudin E Langendorf C Mamiafo Tchoula C Brah S Karani A Gallagher KE Kagucia EW Scott JAG Grais RF
Lancet Infect Dis, (2025). 25:634-642

Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.Bennett JC Deloria Knoll M Kagucia EW Garcia Quesada M Zeger SL Hetrich MK Yang Y Herbert C Ogyu A Cohen AL Yildirim I Winje BA von Gottberg A Viriot D van der Linden M Valentiner-Branth P Suga S Steens A Skoczynska A Sinkovec Zorko N Scott JA Savulescu C Savrasova L Sanz JC Russell F Ricketson LJ Puentes R Nuorti JP Mereckiene J McMahon K McGeer A Mad'arova L Mackenzie GA MacDonald L Lepp T Ladhani SN Kristinsson KG Kozakova J Klein NP Jayasinghe S Ho PL Hilty M Heyderman RS Hasanuzzaman M Hammitt LL Guevara M Grgic-Vitek M Gierke R Georgakopoulou T Galloway Y Diawara I Desmet S De Wals P Dagan R Colzani E Cohen C Ciruela P Chuluunbat U Chan G Camilli R Bruce MG Brandileone MC Bigogo G Ampofo K O'Brien KL Feikin DR Hayford K Pserenade Team
Lancet Infect Dis, (2025). 25:457-470

Comparative performance of the InBios SCoV-2 Detect (TM) IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations.Kutima B Kagucia EW Mwai K Kimani M Sigilai A Mugo D Karanja H Gitonga JN Karani A Akech D Toroitich M Karia B Tuju J Ziraba AK Bigogo G Ochieng C Onyango C Lidechi S Munywoki PK Uyoga S Adetifa IMO Oyier LIO Bejon P Scott JAG Agweyu A Warimwe GM Nyagwange J Kenya Sars-CoV-Serology Consortium
Wellcome Open Res, (2024). 9:349

Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic.Lucinde RK Gathuri H Isaaka L Ogero M Mumelo L Kimego D Mbevi G Wanyama C Otieno EO Mwakio S Saisi M Isinde E Oginga IN Wachira A Manuthu E Kariuki H Nyikuli J Wekesa C Otedo A Bosire H Okoth SB Ongalo W Mukabi D Lusamba W Muthui B Adembesa I Mithi C Sood M Ahmed N Gituma B Giabe M Omondi C Aman R Amoth P Kasera K Were F Nganga W Berkley JA Tsofa B Mwangangi J Bejon P Barasa E English M Scott JAG Akech S Kagucia EW Agweyu A Etyang AO
BMC Infect Dis, (2024). 24:1246

Challenges and Approaches to Establishing Multi-Pathogen Serosurveillance: Findings from the 2023 Serosurveillance Summit.Carcelen AC Kong AC Takahashi S Hegde S Jaenisch T Chu M Rochford R Kostandova N Gurley ES Wesolowski A Azman AS van der Klis FRM den Hartog G Drakeley C Heaney CD Winter AK Salje H Rodriguez-Barraquer I Leung DT Njenga SM Kagucia EW Jambo KC Wolter N Charles RC Saboya-Diaz MI Martin DL Moss WJ
Am J Trop Med Hyg, (2024). 111:1145-1152

Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study.Otiende M Nyaguara A Bottomley C Walumbe D Mochamah G Amadi D Nyundo C Kagucia EW Etyang AO Adetifa IMO Brand SPC Maitha E Chondo E Nzomo E Aman R Mwangangi M Amoth P Kasera K Ng'ang'a W Barasa E Tsofa B Mwangangi J Bejon P Agweyu A Williams TN Scott JAG
Nat Commun, (2023). 14:6879

Symptom prevalence and secondary attack rate of SARS-CoV-2 in rural Kenyan households: A prospective cohort study.Gallagher KE Nyiro J Agoti CN Maitha E Nyagwange J Karani A Bottomley C Murunga N Githinji G Mutunga M Ochola-Oyier LI Kombe I Nyaguara A Kagucia EW Warimwe G Agweyu A Tsofa B Bejon P Scott JAG Nokes DJ
Influenza Other Respir Viruses, (2023). 17:e13185

SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022.Kagucia EW Ziraba AK Nyagwange J Kutima B Kimani M Akech D Ng'oda M Sigilai A Mugo D Karanja H Gitonga J Karani A Toroitich M Karia B Otiende M Njeri A Aman R Amoth P Mwangangi M Kasera K Ng'ang'a W Voller S Ochola-Oyier LI Bottomley C Nyaguara A Munywoki PK Bigogo G Maitha E Uyoga S Gallagher KE Etyang AO Barasa E Mwangangi J Bejon P Adetifa IMO Warimwe GM Scott JAG Agweyu A
Influenza Other Respir Viruses, (2023). 17:e13173

Population immunity to pneumococcal serotypes in Kilifi, Kenya, before and 6 years after the introduction of PCV10 with a catch-up campaign: an observational study of cross-sectional serosurveys.Gallagher KE Adetifa IMO Mburu C Bottomley C Akech D Karani A Pearce E Wang Y Kagucia EW Goldblatt D Hammitt LL Scott JAG
Lancet Infect Dis, (2023). 23:1291-1301

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021.Etyang AO Adetifa I Omore R Misore T Ziraba AK Ng'oda MA Gitau E Gitonga J Mugo D Kutima B Karanja H Toroitich M Nyagwange J Tuju J Wanjiku P Aman R Amoth P Mwangangi M Kasera K Ng'ang'a W Akech D Sigilai A Karia B Karani A Voller S Agoti CN Ochola-Oyier LI Otiende M Bottomley C Nyaguara A Uyoga S Gallagher K Kagucia EW Onyango D Tsofa B Mwangangi J Maitha E Barasa E Bejon P Warimwe GM Scott JAG Agweyu A
PLOS Glob Public Health, (2022). 2:e0000883